Project Details
| Short title | MK-3475-B15 |
|---|---|
| Acronym | KEYNOTE-B15 / EV-304 |
| Status | Active |
| Effective start/end date | 4/08/23 → 28/06/28 |
CTU: A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer
- Zhang, Alison (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
Project: Research